Company intelligence
Mariana Oncology
Precision cancer therapies for a better patient journey: changing how cancer is treated with novel radioligand therapies
Biotechnology Research
96 employees
1 public signals
About Mariana Oncology
Mariana Oncology, a Novartis company, is a fully integrated radiopharmaceutical company developing precision radioligand therapies to transform cancer treatment. We are advancing a pipeline of targeted radioligand therapeutic candidates with the potential to address a broad range of cancers with the goal of optimizing efficacy while allowing patients to live better during their treatment journey.
Verified activity
Signals from Mariana Oncology
1 published signal